Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Receivables (2018 - 2025)

Health Catalyst (HCAT) has disclosed Receivables for 8 consecutive years, with $68.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables rose 14.45% year-over-year to $68.6 million, compared with a TTM value of $68.6 million through Sep 2025, up 14.45%, and an annual FY2024 reading of $69.0 million, up 6.14% over the prior year.
  • Receivables was $68.6 million for Q3 2025 at Health Catalyst, down from $77.1 million in the prior quarter.
  • Across five years, Receivables topped out at $77.1 million in Q2 2025 and bottomed at $43.3 million in Q1 2022.
  • Average Receivables over 5 years is $56.9 million, with a median of $54.2 million recorded in 2023.
  • The sharpest move saw Receivables soared 46.7% in 2023, then fell 9.74% in 2024.
  • Year by year, Receivables stood at $49.6 million in 2021, then fell by 1.47% to $48.9 million in 2022, then soared by 32.99% to $65.0 million in 2023, then rose by 6.14% to $69.0 million in 2024, then dropped by 0.54% to $68.6 million in 2025.
  • Business Quant data shows Receivables for HCAT at $68.6 million in Q3 2025, $77.1 million in Q2 2025, and $71.7 million in Q1 2025.